I have heard $39.5M revs and you are right, some projections would be positive for the stock although they are hard to determine. 2019 numbers should propel the stock and also, maybe a deal or two in the areas of pharma, liquor or beverages.
What’s funny is although rec numbers are great, Aurora has stated they get 3-3.5x premium per gram distributing medical in Germany, with the integration of CMED, Medreleaf and Aurora deautschland. We should hopefully see good numbers, although that integration could have cost us those numbers. Guess it’s a waiting game. GLTY